Dupont Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Dupont Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,080	Closed	-$269K	–	1552
2020 Q2	$269K	Sell	8,080 -722	-8%	-$23K	0.01%	1012
2020 Q1	$239K	Buy	+8,802	New	+$245K	0.01%	956
2018 Q2	–	Sell	-16,962	Closed	-$308K	–	1062
2018 Q1	$308K	Buy	+16,962	New	+$283K	0.01%	758

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Dupont Capital Management's MNTA Position: Q3 2020 in Review

Dupont Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 8,080 shares — an estimated $269K sold.

Dupont Capital Management first reported a position in MNTA in Q1 2018 and held it in 3 quarters. The position peaked at $308K in Q1 2018. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Dupont Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Dupont Capital Management sold 8,080 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $269K.
Dupont Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 3 quarters.
Dupont Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $308K in Q1 2018.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Dupont Capital Management's 13F filing for Q3 2020, filed 29 Oct 2020.